ArticleScientific reports2025
Investigating the expression changes of several key genes in prostate cancer cells under exposure to the ELF pulsed electromagnetic fields.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of the less invasive methods in cancer treatment is the use of Extremely Low-Frequency Pulsed-Electromagnetic Fields (ELF P-EMF). In this study, after culturing and proliferating DU-145 prostate cancer cells, they were exposed to ELF P-EMF with different intensities and times. Then, the cells' viability was examined by applying the MTT test, and their level of apoptosis/ necrosis was analyzed using a flow cytometry test. Then, for the studied groups, RNA extraction steps were performed, and cDNA was subsequently synthesized. Finally, using Real-time PCR, the expression levels of key genes such as PTEN, BAX, BCL-2, and MIR-21 in the targeted cancer cells were examined, and statistically, the significance of their expression differences with the control group was measured using SPSS software. The results indicated that by increasing the ELF P-EMF intensity from 22.6 to 35 mT and the duration of exposure, the mortality rate of cancer cells increased significantly. In addition, exposing cells of this line to ELF P-EMF could induce apoptosis in these cells. Also, applying fields with intensities of 22.6 and 35 mT led to a significant increase in the expression of the tumor suppressor gene PTEN and an increase in the expression of the apoptosis-inducing gene BAX. In addition, applying the field significantly reduced the expression of the oncogene MIR-21 and, to some extent, reduced the expression of the BCL-2 gene, which blocks apoptosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.